Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1056/NEJMc2414217 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Beta-Blockers after Myocardial Infarction. Reply.
N Engl J Med
January 2025
ACTION Group, Paris, France.
Beta-Blockers after Myocardial Infarction.
N Engl J Med
January 2025
Yale School of Medicine, New Haven, CT
Beta-Blockers after Myocardial Infarction.
N Engl J Med
January 2025
Jagiellonian University Medical College, Krakow, Poland
Beta-Blockers after Myocardial Infarction.
N Engl J Med
January 2025
Amsterdam University Medical Center, Amsterdam, the Netherlands
The Appropriate Utilization of Beta-Blockers in Acute Coronary Syndrome Patients: An Improvement Initiative.
Cureus
December 2024
Cardiology, Tata Main Hospital, Jamshedpur, IND.
Background and objective Beta-blockers are a cornerstone in the management of acute coronary syndrome (ACS), effectively reducing myocardial oxygen demand, preventing recurrent ischemia, and lowering the risk of arrhythmias and reinfarction. Despite several established guidelines, such as those by the American College of Cardiology/American Heart Association (ACC/AHA), advocating their use within 24 hours for eligible patients, beta-blockers remain underutilized in clinical practice. This study aimed to analyze beta-blocker utilization patterns in ACS management and evaluate the impact of targeted improvement initiatives on their appropriate use in eligible ACS patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!